Navigation Links
Regenicin CEO to Participate in Live Webcast at OneMedForum Business Development and Finance Conference, January 11th at 4:00 PM PST
Date:1/11/2011

LITTLE FALLS, N.J., Jan. 11, 2011 /PRNewswire/ -- Regenicin, Inc. (OTC Bulletin Board: RGIN) a biotechnology company specializing in the development of regenerative cell therapies to restore the health of damaged tissues and organs, will present at the 4th annual OneMedForum at the Sir Francis Drake Hotel in San Francisco today, Tuesday, January 11th.  Regenicin's CEO, Randall McCoy, will present Regenicin's core business model and strategic approach for bringing new regenerative medicine products to market. The presentation will take place at 4:00 PM PST in the hotel's Renaissance Room and can also be viewed through a live webcast at the following link http://www.ustream.tv/channel/onemedforum.

The 4th Annual OneMedForum

OneMedForum San Francisco 2011, runs concurrently with the J.P. Morgan conference that provides efficient access to the companies that shape the future of the rapidly changing healthcare landscape. The conference's mission is to bring together investors, business development executives, and the brightest new ideas and emerging healthcare and life science companies. Panel sessions will provide Insights for investors to better understand and identify prospective investment opportunities among the 100+ emerging public and private companies that will present over the two and a half days.

About Regenicin

Regenicin, Inc., (OTC Bulletin Board: RGIN) is a biotechnology company specializing in the development of and commercialization of regenerative cell therapies to restore the health of damaged tissues and organs. Regenicin, which was founded in 2010, has assembled a world class team with a proven track record for developing and bringing innovative medical devices and biotechnology produc
'/>"/>

SOURCE Regenicin, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Regenicin COO Receives Citizenship Award from VFW Post 1 in Colorado
2. Regenicin Announces Closing of Private Placement Transaction
3. Regenicin Changes Its Ticker Symbol to RGIN.OB
4. Regenicin Presentation Now Available Online at RetailInvestorConferences.com
5. Regenicin to Present at Event Celebrating Advancements in Regenerative Medicine
6. Regenicin to Present Live at RetailInvestorConferences.com on November 4th
7. Regenicin Appoints Renowned New York Dermatologist, Dr. Gervaise Gerstner to Scientific Advisory Board
8. Regenicin to Form Scientific Advisory Board
9. Regenicin Names Former U.S. Marine Corp Operations Officer, Christopher Hadsall, Chief Operating Officer
10. Former Fujifilm Medical Systems USA Executive John J. Weber Agrees to Join Regenicin™ as a Member of Its Board of Directors and Interim CFO
11. Regenicin Completes Acquisition of Worldwide Exclusive Know-How Technology License from Lonza Walkersville
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... July 3, 2015 ... september 2015 på  http://www.openinnovationinscience.at till det ... Science" som hålls i Wien ... undersökning med internationella forskare och vetenskapsmän som ... hälsovetenskapens två största utmaningar bristen på incitament ...
(Date:7/3/2015)... , July 3, 2015 ... den 22. september 2015 på  http://www.openinnovationinscience.at ... Science", der finder sted i ... nylig undersøgelse af internationale forskere og videnskabsmænd ... de to største udfordringer for sundhedsvidenskaben manglen ...
(Date:7/2/2015)...  Spherix Incorporated (Nasdaq: SPEX ) -- an intellectual property ... intellectual property, today announced a litigation update. ... Services Corp. et al. , Case No. 1:14-cv-00721-GBL-TCB, in ... of Virginia , the Court issued ... key claims in favor of the Defendants on the ...
(Date:7/2/2015)... ... July 02, 2015 , ... In’Tech Medical SAS ( http://www.intech-medical.com ... announced today the acquisition of Turner Medical, Inc ., thus becoming a ... to the Spine Industry. The acquisition of Turner Medical ideally supplements In’Tech Medical’s ...
Breaking Biology Technology:Lansering av världens första program för öppen innovation för att utbilda forskare 2Lansering av världens första program för öppen innovation för att utbilda forskare 3Lancering af verdens første åbne innovationsprogram til uddannelse af forskere 2Lancering af verdens første åbne innovationsprogram til uddannelse af forskere 3Spherix Issues A Litigation Update 2Spherix Issues A Litigation Update 3In'Tech Medical Acquires Turner Medical to Become a World Leader in Orthopedic Contract-Manufacturing 2In'Tech Medical Acquires Turner Medical to Become a World Leader in Orthopedic Contract-Manufacturing 3
... Epeius Biotechnologies,Corporation, a leader in tumor-targeted ... patents for the platform targeting technologies and,molecular ... primary cancers and,metastatic lesions that have spread ... benefit and single-agent-efficacy, as well as,overall safety, ...
... Cardium Therapeutics (NYSE Alternext US: CXM) and its ... the first patient in a study of Hypothermic Radical ... University of California, Irvine . The patient was ... designed to induce localized cooling during robotic-assisted prostatectomy surgery. ...
... 16 InSightec Ltd.,announced today that cancer patients ... their bones have a new online resource for ... provides,background on bone metastases, as well as detailed ... centers in the U.S., Canada and,Israel to evaluate ...
Cached Biology Technology:Epeius Biotech Awarded Patents in Europe for Targeted Genetic Anti-Cancer Medicine: Company Expands Impressive Intellectual Property Estate 2Cardium's InnerCool Announces First Patient Treated With New Tissue-Specific UroCool(TM) System in Robotic-Assisted Prostate Surgery Study 2Cardium's InnerCool Announces First Patient Treated With New Tissue-Specific UroCool(TM) System in Robotic-Assisted Prostate Surgery Study 3Cardium's InnerCool Announces First Patient Treated With New Tissue-Specific UroCool(TM) System in Robotic-Assisted Prostate Surgery Study 4Cardium's InnerCool Announces First Patient Treated With New Tissue-Specific UroCool(TM) System in Robotic-Assisted Prostate Surgery Study 5Cardium's InnerCool Announces First Patient Treated With New Tissue-Specific UroCool(TM) System in Robotic-Assisted Prostate Surgery Study 6Cardium's InnerCool Announces First Patient Treated With New Tissue-Specific UroCool(TM) System in Robotic-Assisted Prostate Surgery Study 7Cardium's InnerCool Announces First Patient Treated With New Tissue-Specific UroCool(TM) System in Robotic-Assisted Prostate Surgery Study 8MyCancerPain.org Launched as Resource for Patients with Painful Bone Metastases 2MyCancerPain.org Launched as Resource for Patients with Painful Bone Metastases 3
(Date:6/25/2015)...  TAKE Solutions Ltd., a global business technology solutions ... Patent and Trademark Office (USPTO) for its "Method for ... Clinical Accelerators to reduce the time taken to standardize ... without the accelerators), thus reducing time to market. ... the heart of the patented Clinical Data Standardization Process ...
(Date:6/24/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/hhwlfj/huawei_ascend ... "Huawei Ascend Mate 7 Fingerprint Sensor - Reverse ... Huawei,s technological choice for the fingerprint sensor ... and Samsung,s one. The Ascend Mate 7 presents ... a main actor in capacitive sensing human interface ...
(Date:6/23/2015)... June 23, 2015   Valencell, a ... results of a recent study that illustrates its ... wrist during activity. In a study conducted at ... along with the Apple Watch against a chest ... rate during activity. The study demonstrated that Valencell,s ...
Breaking Biology News(10 mins):TAKE Solutions Awarded Patent By USPTO 2Huawei Ascend Mate 7 Fingerprint Sensor - Reverse Costing Analysis 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 3
... that some strains of algae, when starved of nutrients, quickly ... the discovery lay dormant until people began to search in ... early 2000s, algal fuel production enjoyed a tremendous vogue, as ... converting "pond scum" to oil. But a recent wave of ...
... 13, 2011 Studies have estimated that converting manure from the ... renewable energy equal to 8 billion gallons of gasoline, or ... Because more and more farmers and communities are interested in ... need for information on the economic feasibility and sustainability of ...
... This press release is available in German . ... long been assumed. This is the conclusion of a study in ... of four major European rivers. It was revealed that 38 per ... have an effect on organisms. According to scientists writing in the ...
Cached Biology News:WUSTL wins $ 2.2 million US Department of Energy grant to build a fuel producing bacterium 2WUSTL wins $ 2.2 million US Department of Energy grant to build a fuel producing bacterium 3WUSTL wins $ 2.2 million US Department of Energy grant to build a fuel producing bacterium 4Does converting cow manure to electricity pay off? 2Pesticides pollute European waterbodies more than previously thought 2Pesticides pollute European waterbodies more than previously thought 3Pesticides pollute European waterbodies more than previously thought 4
... from the SMZ line is a Greenough stereomicroscope ... testing. It is available with a choice of ... space-saving compact base (N2GG). This microscope can be ... projector all at the same time giving you ...
... chemical suppression and thermally stabilized digital conductivity ... of common anions and cations over broad ... equilibrate, and fully automated with Chromeleon® SE ... maximum sample throughput at minimum cost. ...
... UNIchip AV-400 contains 400 unique human ... glass slide. The proteins, a cross ... arrayed in quadruplicate for high-quality results. ... chip layout guarantee high validity and ...
... AV-400 contains 400 unique human proteins ... slide. The proteins, all extracellular proteins ... are arrayed in quadruplicate for high-quality ... specific chip layout guarantee high validity ...
Biology Products: